SCHEMBL6710050

SCHEMBL6710050

Cn1c(C(=O)Nc2ccc(Cl)cc2-c2nnn[nH]2)cc2cccc(OCc3ccco3)c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.38
ALDH1A1 P00352 5/20 0.38
HTT P42858 1/20 0.38
MAPT P10636 8/20 0.38
HPGD P15428 7/20 0.38
KDM4E B2RXH2 5/20 0.38
HSD17B10 Q99714 5/20 0.38
TP53 P04637 2/20 0.38
USP2 O75604 1/20 0.38
NPSR1 Q6W5P4 2/20 0.37
RXFP1 Q9HBX9 1/20 0.37
POLB P06746 3/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
ESR1 P03372 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
LMNA P02545 3/20 0.35
ALOX15 P16050 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
SRPK1 Q96SB4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710246 0.91 GPR35 (0.34) TSHRALDH1A1HTTMAPTHPGD
SCHEMBL6713474 0.89 RXFP1 (0.33) TSHRALDH1A1MAPTHPGDKDM4E
SCHEMBL6707711 0.88 MAPT (0.39) TSHRALDH1A1HTTMAPTHPGD
SCHEMBL6707977 0.88 IRAK4 (0.37) ALDH1A1MAPTHPGDKDM4ERXFP1
SCHEMBL6710193 0.87 PPARG (0.36) MAPTTP53RXFP1POLBSMN1; SMN2
SCHEMBL6711705 0.86 MAPT (0.36) MAPTRXFP1POLBKMT2AMEN1
SCHEMBL6710303 0.86 ALDH1A1 (0.38) TSHRALDH1A1HTTMAPTHPGD
SCHEMBL6709977 0.85 GRM4 (0.36) TSHRALDH1A1MAPTKDM4ERXFP1
SCHEMBL6707611 0.85 LRRK2 (0.40) TSHRALDH1A1HTTMAPTHPGD
SCHEMBL6710394 0.84 KDM1A (0.37) MAPTLMNAGRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 TSHR 3901/4885ALDH1A1 123/4885HTT 2287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.